Bulletin de la Bourse
Hamilton Thorne Ltd. (HTL) inscrit à la Bourse de Toronto
Issuer: | Hamilton Thorne Ltd. (the "Company") |
Security: | Common Shares |
Symbol: | HTL |
Number of securities issued and outstanding: | 146,816,578 |
Number of securities reserved for issuance: | 12,557,899 |
Listing category: | Industrial, Exempt Issuer |
Trading currency: | CDN$ |
Listing and posted for trading date: | September 7, 2023 (at the opening) |
Other market(s): | The common shares have been listed on the TSX Venture Exchange ("TSXV") since November 6, 2009 under the symbol "HTL". The common shares will be delisted from the TSXV on September 7, 2023, upon commencement of trading on the Toronto Stock Exchange. |
Temporary market maker: | Integral Wealth Securities Limited |
Investor relations: | David Wolf Chief Executive Officer (978) 921-2050 Email: ir@hamiltonthorne.ltd Francesco Fragasso Chief Financial Officer (978) 921-2050 Email: ir@hamiltonthorne.ltd |
Incorporation: | Business Corporations Act (Ontario) |
Fiscal year end: | December 31 |
Nature of business: | The Company is a global provider of laboratory equipment, consumables, software and services to the assisted reproductive technology market. The Company develops, manufactures and markets products and delivers services that are primarily used by in-vitro fertilization ("IVF") laboratories and clinics during IVF procedures. |
Transfer agent and registrar: | Computershare Investor Services Inc. at its offices in Toronto. |
Dividends: | No dividends have been paid and none are anticipated in the foreseeable future. |
Sponsorship: | Not Applicable. |
TSX contact: | Selma Thaver, Managing Director, TSX Listings |